Rayno Biopharmaceutical and Diagnostic Stocks In BIG Rally
Biggest movers in Biopharma-Large Caps Still Rule Near All Time Highs
ALXN, AMGN, BIIB, GILD, REGN
Mid and Small Cap movers: AMRI, CBST, IMGN, SGEN
Diagnostic Stocks Pick Up Steam Up Over 2%
EXAS up 8% anticipating colorectal screening test approval.
CPHD, GHDX, NSPH, QDEL, QGEN
Investment posture: maintain 15% cash, stay with Rayno Portfolio stocks, avoid high fliers and small cap speculative stocks. Using ETFs as a marker the sector is at the low end of a rising channel up 17% YTD.
Disclosure: I am long ACHN.
Additional disclosure: I am long Fidelity Select Biotechnology Fund (MUTF:FBIOX) and short selective mid cap stocks as a hedge.